Rankings
▼
Calendar
MNKD Q3 2023 Earnings — MannKind Corporation Revenue & Financial Results | Market Cap Arena
MNKD
MannKind Corporation
$813M
Q3 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$51M
+56.1% YoY
Gross Profit
$37M
72.2% margin
Operating Income
$5M
9.9% margin
Net Income
$2M
3.4% margin
EPS (Diluted)
$0.01
QoQ Revenue Growth
+5.4%
Cash Flow
Operating Cash Flow
$9M
Free Cash Flow
-$3M
Stock-Based Comp.
$5M
Balance Sheet
Total Assets
$320M
Total Liabilities
$572M
Stockholders' Equity
-$252M
Cash & Equivalents
$83M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$51M
$33M
+56.1%
Gross Profit
$37M
$15M
+140.8%
Operating Income
$5M
-$10M
+153.0%
Net Income
$2M
-$14M
+111.9%
Revenue Segments
License and Service
$10M
100%
← FY 2023
All Quarters
Q4 2023 →